November 12, 2025 - Inventiva (Euronext Paris and Nasdaq: IVA) ('Inventiva' or the 'Company'), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback